Last Update Time:
04-Mar-2025 16:00:00
ISIN:
INE947I01017
Sector:
Healthcare
Symbol:
LOTUSEYE
Lotus Eye Hospital and Institute Limited
₹58.50
₹-0.63
(-1.07%)
▼
Prev. Close
₹59.13
Open
₹58.98
Close
₹57.51
Range
₹55.58 - ₹61.43
High
₹60.23
Low
₹56.26
Ind. Close
₹0.00
VWAP
₹58.86
The current stock price of Lotus Eye Hospital and Institute Limited is ₹58.50, with a target price range between ₹55.58 and ₹61.43. The stock has experienced a price change of ₹-0.63 (-1.07%), reflecting recent market volatility.
Today's opening price was ₹58.98, while the previous close stood at ₹59.13.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Lotus Eye Hospital and Institute Limited Price Chart
Lotus Eye Hospital and Institute Limited Pre Open Market Overview: 04-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 0
- Previous Close Price: 59.13
- Change: -59.13%
- Total Traded Volume: 0
- Total Buy Quantity: 2,623
- Total Sell Quantity: 951
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 0.00 | 0.00 | 0.00 |
| 56.00 | 1.00 | 0.00 |
| 56.02 | 30.00 | 0.00 |
| 56.56 | 30.00 | 0.00 |
| 57.50 | 1,000.00 | 0.00 |
| 59.13 | 0.00 | 50.00 |
| 60.90 | 0.00 | 100.00 |
| 61.00 | 0.00 | 100.00 |
| 61.50 | 0.00 | 300.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 2623
Total Sell Quantity: 951
Shareholding Patterns of Lotus Eye Hospital and Institute Limited
Key Trade Statistics of Lotus Eye Hospital and Institute Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.63 |
| Traded Value (₹ Cr.) | 0.37 |
| Total Market Cap (₹ Cr.) | 121.66 |
| Free Float Market Cap (₹ Cr.) | 71.21 |
| Impact cost | 1.17 |
| Quantity Traded | 63,494.00 |
| Deliverable Quantity | 59,904.00 |
| % of Quantity to Traded | 94.35 |
| Security VaR | 20.46 |
| Index VaR | N/A |
| VaR Margin | 21.5 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 25 |
| Face Value | 10 |
Key Price Statistics of Lotus Eye Hospital and Institute Limited
The 52-week high for Lotus Eye Hospital and Institute Limited was ₹90.98, recorded on 30-Sep-2024. On the other hand, the 52-week low stands at ₹48.50, with the lowest value recorded on 05-Mar-2024.
The upper band for trading is ₹70.95, and the lower band is ₹47.30. The price band is 20%.
The stock's daily volatility stands at 3.10, while the annualized volatility is 59.23. The tick size for trading is ₹0.01.
| Price Information | Details |
|---|---|
| 52 Week High (30-Sep-2024) | 90.98 |
| 52 Week Low (05-Mar-2024) | 48.50 |
| Upper Band | 70.95 |
| Lower Band | 47.30 |
| Price Band (%) | 20 |
| Daily Volatility | 3.10 |
| Annualised Volatility | 59.23 |
| Tick Size | 0.01 |
Key Securities Statistics of Lotus Eye Hospital and Institute Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 11-Jul-2008 |
| Adjusted P/E | 251.71 |
| Symbol P/E | 240.46 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Hospital |
Security Status of Lotus Eye Hospital and Institute Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Lotus Eye Hospital and Institute Limited
| Subject | Date |
|---|---|
| Integrated Filing- Financial | 17-Feb-2025 |
| Copy of Newspaper Publication | 13-Feb-2025 |
| Financial Result Updates | 12-Feb-2025 |
| Outcome of Board Meeting | 12-Feb-2025 |
| Board Meeting Intimation | 31-Jan-2025 |
| Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 06-Jan-2025 |
| Registrar & Share Transfer Agent Update | 02-Jan-2025 |
| Trading Window | 27-Dec-2024 |
Corporate Actions of Lotus Eye Hospital and Institute Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Dividend - Re 0.50 Per Share | 18-Sep-2023 |
| 10 | Annual General Meeting | 18-Sep-2023 |
| 10 | Annual General Meeting/Dividend - Re 0.50 Per Sh | 08-Sep-2022 |
| 10 | Annual General Meeting/Dividend - Rs 0.50 Per Share | 08-Sep-2021 |
| 10 | Annual General Meeting | 19-Nov-2020 |
| 10 | Annual General Meeting | 16-Sep-2019 |
| 10 | Annual General Meeting/Dividend Re 0.5 Per Share | 14-Sep-2018 |
| 10 | Annual General Meeting/Dividend Re 0.5 Per Share | 14-Sep-2018 |
| 10 | Annual General Meeting/Dividend - Re 0.50 Per Share | 02-Aug-2017 |
| 10 | Annual General Meeting | 23-Aug-2016 |
| 10 | Annual General Meeting | 18-Sep-2015 |
| 10 | Annual General Meeting | 16-Sep-2014 |
| 10 | Annual General Meeting | 17-Sep-2013 |
| 10 | Annual General Meeting | 14-Sep-2012 |
| 10 | Annual General Meeting | 20-Sep-2011 |
| 10 | Annual General Meeting | 08-Sep-2010 |
| 10 | Annual General Meeting | 23-Sep-2009 |
| 10 | Annual General Meeting | 24-Sep-2008 |
Board Meetings of Lotus Eye Hospital and Institute Limited
Financial Results of Lotus Eye Hospital and Institute Limited
Company Directory of Lotus Eye Hospital and Institute Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.lotuseye.org | Registered Office | S.F. No. 770/12, Civil Aerodrome Post, Avinashi Road, |
COIMBATORE |
| www.lotuseye.org | Transfer Agent | S.K.D.C. Consultants Limited 1391/A-1, 3rd floor, Kanapathy Towers Sathy Road, Ganapathy |
COIMBATORE |
Insider Trading of Lotus Eye Hospital and Institute Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | S Rajkumar | 7488650 | Sell |
| 7(2) | S Rajkumar | 6245352 | Sell |
| 7(2) | S Rajkumar | 173281731 | Sell |
| 7(2) | S Rajkumar | 31500000 | Pledge Revoke |
| 7(2) | S Rajkumar | 17585079 | Sell |
| 7(2) | S Rajkumar | 1651418 | Buy |
| 7(2) | S Rajkumar | 1916339 | Buy |
| 7(2) | S Rajkumar | 31500000 | Pledge |
| 7(2) | DR. K.S RAMALINGAM | 1962814 | Buy |
| 7(2) | SANGEETHA SUNDARAMOORTHY | 240380 | Buy |
| 7(2) | DR. K.S RAMALINGAM | 2046123 | Buy |
| 7(2) | SANGEETHA SUNDARAMOORTHY | 197685 | Buy |
| 7(2) | DR. K.S RAMALINGAM | 229192 | Buy |
| 7(2) | DR. KAVETHA SUNDARAMOORTHY | 263550750 | Buy |
| 7(2) | DR. KAVETHA SUNDARAMOORTHY | 12622250 | Buy |
| 7(2) | KALIANNAGOUNDER SUNDARAMOORTHYD | 94262 | Buy |
| 7(2) | KALIANNAGOUNDER SUNDARAMOORTHYD | 138644 | Buy |
| 7(2) | KALIANNAGOUNDER SUNDARAMOORTHYD | 285820 | Buy |
| 7(2) | KALIANNAGOUNDER SUNDARAMOORTHYD | 186156 | Buy |
| 7(2) | KALIANNAGOUNDER SUNDARAMOORTHYD | 277542 | Buy |
Annual Reports of Lotus Eye Hospital and Institute Limited
Investor Complaints of Lotus Eye Hospital and Institute Limited
Event Calendar of Lotus Eye Hospital and Institute Limited
| Purpose | Details |
|---|---|
| Board Meeting Postponed | The Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on May 24, 2010 to consider and take on record the Audited Financial Results for the fourth quarter / year ended March 31, 2010. The Company has now informed the Exchange that the meeting of the Board of Directors is postponed to May 26, 2010, to consider and take on record the Audited Financial Results for the fourth quarter / year ended March 31, 2010. |
| Financial Results | To consider and approve the Annual Accounts for the financial year ended March 31, 2012 and also un audited financial results for the first quarter ended June 30, 2012. |
| Results | To consider and approve the unaudited financial results for the third quarter ended December 31, 2012. |
| Results | To consider and approve the audited financial results for the fourth quarter and also year ended March 31, 2013. |
| Results | to consider and approve the un audited financial results for the first quarter ended 30th June, 2013. |
| Results | to consider and approve the un audited financial results for the second quarter ended September 30, 2013. |
| Results | To consider and approve the unaudited financial results for the third quarter ended December 31, 2013. |
| Results | To consider and approve the audited financial results for the fourth quarter / year ended March 31, 2014. |
| Results | To consider and approve the un audited financial results for the first quarter ended June 30, 2014. |
| Results | To consider and approve the unaudited financial results for the quarter ended September 30, 2014. |
| Results | To consider and approve the un audited financial results for the third quarter ended December 31, 2014. |
| Results | To consider and approve the audited financial results for the fourth quarter / year ended March 31, 2015. |
| Results | to consider and approve the unaudited financial results for the first quarter ended June 30, 2015. |
| Results | To consider and approve the unaudited financial result for half-year ended September 30, 2015. |
| Results | to consider and approve the unaudited financial results for quarter and nine months ended December 31, 2015. |
| Results | To, inter-alia consider and approve the Audited Financial Results for the Quarter and Year ended March 31, 2016. |
| Results | To, inter-alia consider and approve the Un-audited Financial Results for the Quarter ended June 30, 2016. |
| Results | to, inter-alia consider and approve the Un-audited Financial Results for the Quarter/Half Year ended September 30, 2016. Further the trading window, in terms of code of conduct under the SEBI (Prohibition of Insider Trading) Regulations, 2015, shall remain closed from October 29, 2016 to November 16, 2016 (both days inclusive). |
| Results/Others | to, inter-alia consider and approve the Un-audited Financial Results for the Quarter/Nine Months ended December 31, 2016. |
| Results/Others | To consider the following: 1. Audited Financial Results for the Quarter/Year ended March 31, 2017; 2. Any other business. |
| Results/Dividend | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held May 27, 2017, To consider the following: 1. Audited Financial Results for the Quarter/Year ended March 31, 2017; 2. Any other business. The Company has now informed the Exchange that, to consider recommendation of dividend for the financial year ended on March 31, 2017, if any, subject to approval of the Members at the ensuing Annual General Meeting of the Company. (Purpose Revised) |
| Results | To inter-alia consider and approve the Un-audited Financial Results for the quarter ended June 30, 2017. |
| Results | To inter-alia consider and approve the Un-audited Financial Results for the quarter ended September 30, 2017. |
| Results | To inter-alia consider and approve the Un-audited Financial Results for the quarter ended December 31, 2017. |
| Dividend | To consider dividend |
| Dividend | To consider recommendation of dividend for the financial year ended on March 31, 2018 if any, subject to approval of the Members at the ensuing Annual General meeting of the Company. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2018 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend/Other business matters | To consider and approve the financial results for the period ended March 31, 2019, dividend and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Other business matters | We would like to inform that a meeting of the Board of Directors of the company has been scheduled to be held on Monday, 13th January, 2020 on a shorter notice with the consent of all the directors at the registered office of the company at 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore 641014 to transact the following business:1. To appoint the chief financial officer of the company.2. To consider any other matters with the permission of the chair |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Board meeting Rescheduled | Lotus Eye Hospital and Institute Limited has informed the Exchange that the meeting of the Board of Directors of the Company scheduled to be held on Jun 29, 2020 To consider and approve the financial results for the period ended March 31, 2020 has been postponed |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Lotus Eye Hospital and Institute Limited has informed the Exchange about Board Meeting to be held on 09-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Lotus Eye Hospital and Institute Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2022 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2023 |
| Dividend | To consider dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2024 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Lotus Eye Hospital and Institute Limited
Voting Results of Lotus Eye Hospital and Institute Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 13-AUG-2024 | AGM | Adoption of the Audited Financial Statements of the Company for the financial year ended 31st March, 2024, including the Balance Sheet as at 31st March, 2024, the Statement of Profit and Loss Account and the Cash Flow Statement for the financial year ended on that date and the Reports of the Board of Directors and the Auditors thereon. |
| 13-AUG-2024 | AGM | To appoint a director in the place of Dr. Kavetha Sundaramoorthy (DIN: 02050806) who retires by rotation and being eligible, offers herself for re-appointment. |
| 25-SEP-2023 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2023, including the Balance Sheet as at 31st March, 2023, the Statement of Profit and Loss Account and the Cash Flow Statement for the financial year ended on that date and the Reports of the Board of Directors and the Auditors thereon |
| 25-SEP-2023 | AGM | To approve the revision in remuneration payable to Ms Sangeetha Sundaramoorthy (DIN:01859252) Managing Director of the company |
| 25-SEP-2023 | AGM | To re-appoint Ms Sangeetha Sundaramoorthy (DIN: 01859252) as Managing Director of the Company for a term of 5 years |
| 25-SEP-2023 | AGM | To appoint a director in the place of Dr. Kavetha Sundaramoorthy (DIN: 02050806) who retires by rotation and being eligible, offers herself for re-appointment.nnn |
| 25-SEP-2023 | AGM | To declare final dividend of Rs 0.50/- per equity share for the financial year ended 31st March 2023. |
| 18-MAR-2023 | Postal Ballot | Appointment of Mr Karthik Veeramani as an Independent Director |
| 18-MAR-2023 | Postal Ballot | Appointment of Mr Perumalsamy Mahendran as an Independent Director |
| 22-SEP-2022 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for thefinancial year ended 31st March, 2022, including the Balance Sheet as at 31st March, 2022,the Statement of Profit and Loss Account and the Cash Flow Statement for the financial year ended on that date and the Reports of the Board of Directors and the Auditors thereon.n |
| 22-SEP-2022 | AGM | To re-appoint Anbarasu & Jalapathi Associates, Chartered Accountants (ICAI Firm Regn.No 0107958S) as statutory auditors to hold office from the conclusion of 25th Annual General Meeting till the Conclusion of 30th Annual General meeting and fixation of remuneration.n |
| 22-SEP-2022 | AGM | To declare final dividend of Rs 0.50 per equity share for the Financial year ended 31st March 2022.n |
| 22-SEP-2022 | AGM | To appoint a director in the place of Dr. Kavetha Sundaramoorthy (DIN: 02050806) who retires by rotation and being eligible, offers herself for re-appointment.ￂﾠn |
| 17-SEP-2021 | AGM | 1. To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2021, including the Balance Sheet as at 31st March, 2021, the Statement of Profit and Loss and the Cash Flow Statement for the financial year ended on that date and the Reports of the Board of Directors and the Auditors thereon. |
| 17-SEP-2021 | AGM | Appointment of Dr. K.S. Ramalingam [DIN: 01016571] as Executive Director & Chief Executive Officer. |
| 17-SEP-2021 | AGM | 4. Appointment of Dr. S. Natesan (DIN: 09012904) as an Independent Director |
| 17-SEP-2021 | AGM | 3. To declare Final Dividend on equity shares for the financial year ended March 31, 2021 |
| 17-SEP-2021 | AGM | To appoint a director in place of Dr. Kavetha Sundaramoorthy (holding DIN: 02050806) who retires by rotation and being eligible, offers herself for re-appointment. |
| 28-NOV-2020 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2020, including the Balance Sheet as at 31st March, 2020, the Statement of Profit and Loss and the Cash Flow Statement for the financial year ended on that date and the Reports of the Board of Directors and the Auditors thereon. |
| 28-NOV-2020 | AGM | To appoint a director in place of Dr. Kavetha Sundaramoorthy (holding DIN: 02050806) who retires by rotation and being eligible, offers herself for re-appointment. |
FAQs on Lotus Eye Hospital and Institute Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.